Advances in prognostic markers for colorectal cancer

L Duan, W Yang, X Wang, W Zhou… - Expert Review of …, 2019 - Taylor & Francis
Introduction: Colorectal cancer (CRC) is one of the most common malignant tumors
worldwide and contributes significantly to cancer-related deaths. Since CRC is largely …

Epigenetic biomarkers in colorectal cancer

M Verma, V Kumar - Molecular diagnosis & therapy, 2017 - Springer
Developments in the diagnosis and treatment of colorectal cancer (CRC) have been made
in the last decade, but the overall survival rate of patients with CRC has not improved …

A 19-Gene expression signature as a predictor of survival in colorectal cancer

NA Abdul Aziz, NM Mokhtar, R Harun… - BMC medical …, 2016 - Springer
Background Histopathological assessment has a low potential to predict clinical outcome in
patients with the same stage of colorectal cancer. More specific and sensitive biomarkers to …

Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling

J Martinez-Romero, S Bueno-Fortes, M Martín-Merino… - BMC genomics, 2018 - Springer
Background Identification of biomarkers associated with the prognosis of different cancer
subtypes is critical to achieve better therapeutic assistance. In colorectal cancer (CRC) the …

[HTML][HTML] A seven-gene signature predicts overall survival of patients with colorectal cancer

H Chen, X Sun, W Ge, Y Qian, R Bai, S Zheng - Oncotarget, 2016 - pmc.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is a major cause of global cancer mortality. Gene expression
profiles can help predict prognosis of patients with CRC. In most of previous studies, disease …

PHF5A promotes colorectal cancer progression by alternative splicing of TEAD2

Y Chang, Y Zhao, L Wang, M Wu, C He… - … Therapy-Nucleic Acids, 2021 - cell.com
Dysregulated alternative splicing (AS) plays critical roles in driving cancer progression, and
the underlying mechanisms remain largely unknown. Here, we demonstrated that PHF5A, a …

Paeonol exerts anti-tumor activity against colorectal cancer cells by inducing G0/G1 phase arrest and cell apoptosis via inhibiting the Wnt/β-catenin signaling …

LH Liu, RJ Shi, ZC Chen - International Journal of …, 2020 - spandidos-publications.com
Paeonol is a simple phenolic compound isolated from herbal root bark, which has been
reported to possess numerous biological and pharmacological characteristics, including a …

Cluster analysis on high dimensional RNA-seq data with applications to cancer research-An evaluation study

L Vidman, D Källberg, P Rydén - PLoS One, 2019 - journals.plos.org
Background Clustering of gene expression data is widely used to identify novel subtypes of
cancer. Plenty of clustering approaches have been proposed, but there is a lack of …

The prognostic 97 chemoresponse gene signature in ovarian cancer

A Matondo, YH Jo, M Shahid, TG Choi, MN Nguyen… - Scientific reports, 2017 - nature.com
Patient diagnosis and care would be significantly improved by understanding the
mechanisms underlying platinum and taxane resistance in ovarian cancer. Here, we aim to …

[HTML][HTML] An 8-gene signature for prediction of prognosis and chemoresponse in non-small cell lung cancer

M Shahid, TG Choi, MN Nguyen, A Matondo, YH Jo… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Identification of a potential gene signature for improved diagnosis in non-small cell lung
cancer (NSCLC) patient is necessary. Here, we aim to establish and validate the prognostic …